Zoonotik Hastalıklar ve Nanoteknoloji
Özet
Zoonotik hastalıklar hayvanlardan insanlara veya insanlarda hayvanlara bulaşabilen ve halk sağlığı, hayvan sağlığı ile çevresel sürdürülebilirlik üzerinde ciddi etkileri olan bulaşıcı hastalık grubudur. Zoonotik hastalıkların etkenleri viral, bakteriyel, paraziter veya fungal kaynaklı olabilir. Bu hastalıklarla etkin mücadele; erken tanı, etkili tedavi, hedefe yönelik aşılamalar ve çevresel bulaş kaynaklarının kontrolünü gerektirir. Nanoteknoloji, sunduğu yüksek fonksiyonelleştirme imkânı ve biyolojik sistemlerle uyumlu yapısı sayesinde zoonozlarla mücadelede giderek artan bir öneme sahiptir. Nanoteknoloji zoonotik hastalıkların tanı, aşı geliştirme, ilaç taşıma, antimikrobiyal dirençle mücadele, hayvansal üretim süreçleri, su arıtımı, atık yönetimi ve çevresel etkiler bağlamında potansiyel çözümler sunmaktadır. Ayrıca teranostik sistemler, yapay zeka destekli nanobiyosensörler ve sürdürülebilir nanomateryal kullanımı gibi araştırma alanlarının gelecekte öne çıkması beklenmektedir. Nanoteknoloji, “Tek Sağlık” yaklaşımını destekleyen çok disiplinli bir araç olarak değerlendirilmelidir.
Zoonotic diseases, which are transmissible from animals to humans or humans to animals, pose serious threats to public health, animal welfare, and environmental sustainability. The agents of zoonotic diseases can be viral, bacterial, parasitic or fungal. Effective management of these diseases requires early diagnosis, targeted treatment, efficient vaccination strategies, and control of environmental transmission routes. Nanotechnology, with its high functionalization potential, and biocompatibility, offers promising innovations in diagnosing, preventing, and controlling zoonoses. Nanotechnology offers potential solutions for the diagnosis of zoonotic diseases, vaccine development, drug delivery, combating antimicrobial resistance, animal production processes, water treatment, waste management and environmental impacts. In addition, research areas such as theranostic systems, artificial intelligence-supported nanobiosensors and sustainable nanomaterial use are expected to stand out in the future. Nanotechnology should be considered as a multidisciplinary tool supporting the “One Health” approach.
Referanslar
Karesh WB, Dobson A, Lloyd-Smith JO, et al. Ecology of zoonoses: natural and unnatural histories. The Lancet. 2012;380(9857): 1936–45. doi:10.1016/S0140-6736(12)61678-X.
International Monetary Fund (IMF). World Economic Outlook, April 2023: A Rocky Recovery 2023. (08 Haziran 2025 tarihinde https://www.imf.org/en/Publications/WEO/Issues/2023/04/11/world-economic-outlook-april-2023 adresinden ulaşılmıştır).
Adkinson AY, Çağlarırmak N, Hepçimen AZ. Hayvanlardan insanlara geçen hastalıklar ve gıda güvenliği. Mersin Üniversitesi Sağlık Bilim Dergisi. 2022;15(3): 594–604.
Beach MA, Nayanathara U, Gao Y, et al. Polymeric Nanoparticles for Drug Delivery. Chemical Reviews. 2024;124(9): 5505–616. doi:10.1021/acs.chemrev.3c00705.
Destoumieux-Garzón D, Mavingui P, Boetsch G, et al. The one health concept: 10 years old and a long road ahead. Frontiers in Veterinary Science. 2018;5: 14. doi: 10.3389/fvets.2018.00014.
Rahman MT, Sobur MA, Islam MS, et al. Zoonotic diseases: etiology, impact, and control. Microorganisms. 2020;8(9): 1405. doi: 10.3390/microorganisms8091405.
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798): 270–273. doi:10.1038/s41586-020-2012-7
Peiris JS, Guan Y, Yuen K. Severe acute respiratory syndrome. Nature Medicine. 2004;10(Suppl 12): S88–97. doi:10.1038/nm1143.
Zaki AM, Van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N England Journal of Medicine. 2012;367(19): 1814–1820. doi:10.1056/NEJMoa1211721.
Fooks AR, Banyard AC, Horton DL, et al. Current status of rabies and prospects for elimination. The Lancet. 2014;384(9951): 1389–1399. doi:10.1016/S0140-6736(13)62707-5.
Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA. 2013;310(3): 308–315. doi:10.1001/jama.2013.8042
Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harbor Perspectives in Medicine. 2011;1(1): a006841. doi:10.1101/cshperspect.a006841.
Luby SP. The pandemic potential of Nipah virus. Antiviral Research. 2013;100(1): 38–43. doi:10.1016/j.antiviral.2013.07.011.
Field H, Young P, Yob JM, et al. The natural history of Hendra and Nipah viruses. Microbes and Infection. 2001;3(4): 307–314. doi:10.1016/s1286-4579(01)01384-3.
Ergönül Ö. Crimean-Congo haemorrhagic fever. The Lancet. Infectious Diseases. 2006;6(4): 203–214. doi:10.1016/S1473-3099(06)70435-2.
Musso D, Gubler DJ. Zika Virus. Clinical Microbiology Reviews. 2016;29(3): 487–524. doi:10.1128/CMR.00072-15.
Corbel MJ. Brucellosis in humans and animals. Food and Agriculture Organization of the United Nations, World Health Organization & World Organisation for Animal Health; 2006.
World Health Organization, Food and Agriculture Organization of the United Nations & World Organisation for Animal Health. Anthrax in humans and animals. (09 Haziran 2025 tarihinde https://books.google.com/books?hl=tr&lr=&id=EKYihvnaA7oC&oi=fnd&pg=PP2&dq=Turnbull,+P.+C.+(2008).+Anthrax+in+humans+and+animals.+World+Health+Organization.&ots=EkfpAEhtdQ&sig=HaMpE-TtLu1uWb6XMFuoB7fXsNU adresinden ulaşılmıştır).
Michel AL, Müller B, Van Helden PD. Mycobacterium bovis at the animal–human interface: A problem, or not?. Veterinary Microbiology. 2010;140(3-4): 371–381. doi:10.1016/j.vetmic.2009.08.029.
Majowicz SE, Musto J, Scallan E, et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2010;50(6): 882–889. doi:10.1086/650733.
Haake DA, Levett PN. Leptospirosis in humans. Current Topics in Microbiology and Immunology. 2015;387: 65–97. doi:10.1007/978-3-662-45059-8_5.
Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA. 2001;285(21): 2763–2773. doi:10.1001/jama.285.21.2763.
Acheson D, Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2001;32(8): 1201–1206. doi:10.1086/319760.
Bottone EJ. Yersinia enterocolitica: overview and epidemiologic correlates. Microbes and Infection. 1999;1(4): 323–333. doi:10.1016/s1286-4579(99)80028-8
Beeckman DSA, Vanrompay DCG. Zoonotic Chlamydophila psittaci infections from a clinical perspective. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 2009;15(1): 11–17. doi:10.1111/j.1469-0691.2008.02669.x.
Maurin M, Raoult D. Q Fever. Clinical Microbiology Reviews. 1999;12(4): 518–553. doi:10.1128/CMR.12.4.518.
Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. International Journal for Parasitology. 2000;30(12-13): 1217–1258. doi:10.1016/s0020-7519(00)00124-7.
Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PloS One. 2012;7(5): e35671. doi:10.1371/journal.pone.0035671.
Eckert J, Deplazes P. Biological, Epidemiological, and clinical aspects of Echinococcosis, a zoonosis of increasing concern. Clinical Microbiology Reviews. 2004;17(1): 107–135. doi:10.1128/CMR.17.1.107-135.2004.
Mendlovic F, Fleury A, Flisser A. Zoonotic Taenia infections with focus on cysticercosis due to Taenia solium in swine and humans. Research in Veterinary Science. 2021;134: 69–77. doi:10.1016/j.rvsc.2020.11.015.
Thompson RA. The zoonotic significance and molecular epidemiology of Giardia and giardiasis. Veterinary Parasitology. 2004;126(1-2): 15–35. doi:10.1016/j.vetpar.2004.09.008.
Dupouy-Camet J, Bruschi F. Management and diagnosis of human trichinellosis. Dupouy-Camet J, Murrell KD (eds.) FAO/WHO/OIE guidelines for the surveillance, management, prevention and control of trichinellosis. Paris: FAO/WHO/OIE; 2007. p. 37–61.
Pumipuntu N, Piratae S. Cryptosporidiosis: A zoonotic disease concern. Veterinary World. 2018;11(5): 681–686. doi:10.14202/vetworld.2018.681-686
Chermette R, Ferreiro L, Guillot J. Dermatophytoses in animals. Mycopathologia. 2008;166(5-6): 385–405. doi:10.1007/s11046-008-9102–9107.
Barros MBDL, De Almeida Paes R, Schubach AO. Sporothrix schenckii and Sporotrichosis. Clinical Microbiology Reviews. 2011;24(4): 633–654. doi:10.1128/CMR.00007-11.
Horefti E. The importance of the One Health concept in combating zoonoses. Pathogens (Basel, Switzerland). 2023;12(8): 977. doi:10.3390/pathogens12080977.
Yeh YC, Creran B, Rotello VM. Gold nanoparticles: preparation, properties, and applications in bionanotechnology. Nanoscale. 2012;4(6): 1871–1880. doi:10.1039/c1nr11188d.
Baptista PV, Koziol-Montewka M, Paluch-Oles J, et al. Gold-nanoparticle-probe–based assay for rapid and direct detection of Mycobacterium tuberculosis DNA in clinical samples. Clinical Chemistry. 2006;52(7): 1433–1434. doi:10.1373/clinchem.2005.065391.
Zarei M. Advances in point-of-care technologies for molecular diagnostics. Biosens & Bioelectron. 2017;98: 494–506. doi:10.1016/j.bios.2017.07.024.
Ardekani LS, Thulstrup PW. Gold nanoparticle-mediated lateral flow assays for detection of host antibodies and COVID-19 proteins. Nanomaterials (Basel, Switzerland). 2022;12(9): 1456. doi:10.3390/nano12091456.
Prakash C, Kumar B, Singh RP, et al. Development and evaluation of a gold nanoparticle based Lateral Flow assay (LFA) strip test for detection of Brucella spp. Journal of Microbiological Methods. 2021;184: 106185. doi:10.1016/j.mimet.2021.106185
Chirathaworn C, Chantaramalai T, Sereemaspun A, et al. Detection of Leptospira in urine using anti-Leptospira-coated gold nanoparticles. Comparative Immunology, Microbiology and Infectious Diseases. 2011;34(1): 31–34. doi:10.1016/j.cimid.2009.10.006.
Seele PP, Dyan B, Skepu A, et al. Development of gold-nanoparticle-based lateral flow immunoassays for rapid detection of TB ESAT-6 and CFP-10. Biosensors. 2023;13(3): 354. doi:10.3390/bios13030354.
Jin K, Zhao J, Chen H, et al. On-site visual detection of Nipah virus combining a reverse transcription recombinase-aided amplification with a lateral-flow dipstick assay. Journal of Integrative Agriculture. 2025;24(2): 790–794.
Sharma AS, Lee NY. Advancements in visualizing loop-mediated isothermal amplification (LAMP) reactions: a comprehensive review of colorimetric and fluorometric detection strategies for precise diagnosis of infectious diseases. Coordination Chemistry Reviews. 2024;509: 215769. doi: 10.1016/j.ccr.2024.215769.
Inbaraj BS, Chen BH. Nanomaterial-based sensors for detection of foodborne bacterial pathogens and toxins as well as pork adulteration in meat products. Journal of Food and Drug Analysis. 2016;24(1): 15–28. doi:10.1016/j.jfda.2015.05.001.
Dang S, Sui H, Zhang S, et al. CRISPR-Cas12a test strip (CRISPR/CAST) package: In-situ detection of Brucella from infected livestock. BMC Veterinary Research. 2023;19(1): 202.
Chaudhary N, Weissman D, Whitehead KA. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nature reviews. Drug discovery. 2021;20(11): 817–838. doi:10.1038/s41573-021-00283-5.
Zhao L, Seth A, Wibowo N, et al. Nanoparticle vaccines. Vaccine. 2014;32(3): 327–337. doi:10.1016/j.vaccine.2013.11.069.
Gregoriadis G. Liposome Technology: Entrapment of drugs and other materials into liposomes. Boca Raton: CRC Press; 2016.
Kammona O, Kiparissides C. Recent advances in nanocarrier-based mucosal delivery of biomolecules. Journal of Controlled Release: Official Journal of the Controlled Release Society. 2012;161(3): 781–794. doi:10.1016/j.jconrel.2012.05.040.
Smith DM, Simon JK, Baker Jr JR. Applications of nanotechnology for immunology. Nature reviews. Immunology. 2013;13(8): 592–605. doi:10.1038/nri3488.
Heidary M, Dashtbin S, Ghanavati R, et al. Evaluation of brucellosis vaccines: a comprehensive review. Frontiers in Veterinary Science. 2022;9: 925773. doi:10.3389/fvets.2022.925773.
Quan FS, Lee YT, Kim KH, et al. Progress in developing virus-like particle influenza vaccines. Expert Review of Vaccines. 2016;15(10): 1281–1293. doi:10.1080/14760584.2016.1175942.
Sahin U, Muik A, Derhovanessian E, et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature. 2020;586(7830): 594–599. doi:10.1038/s41586-020-2814-7.
Hojatizade M, Soleymani M, Tafaghodi M, et al. Chitosan nanoparticles loaded with whole and soluble leishmania antigens, and evaluation of their immunogenecity in a mouse model of leishmaniasis. Iranian journal of immunology: IJI. 2018;15(4): 281–293. doi:10.22034/IJI.2018.39397.
Madhusudana SN, Padinjaremattathil Thankappan U, Desai A, et al. Enhancement of immunogenicity and efficacy of a plasmid DNA rabies vaccine by nanoformulation with a fourth-generation amine-terminated poly(ether imine) dendrimer. International Journal of Nanomedicine. 2014;627–634. doi:10.2147/IJN.S53415.
Gregory AE, Titball R, Williamson D. Vaccine delivery using nanoparticles. Frontiers in Cellular and Infection Microbiology. 2013;3: 13. doi:10.3389/fcimb.2013.00013.
Getahun H. Antimicrobial Resistance. Raviglione MCB, Tediosi F, Villa S, Casamitjana N, Plasència A (eds.) Global Health Essentials [Internet]. Cham: Springer International Publishing; 2023. p. 143–147. doi:10.1007/978-3-031-33851-9_22.
Van Boeckel TP, Brower C, Gilbert M, et al. Global trends in antimicrobial use in food animals. Proceedings of the National Academy of Sciences of the United States of America. 2015;112(18): 5649–5654. doi:10.1073/pnas.1503141112.
Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnology Advances. 2009;27(1): 76–83. doi:10.1016/j.biotechadv.2008.09.002.
Durán N, Durán M, De Jesus MB, et al. Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity. Nanomedicine: Nanotechnology, Biology, and Medicine. 2016;12(3): 789–799. doi:10.1016/j.nano.2015.11.016.
Otieno DB, Bosire GO, Onyari JM, et al. Antibacterial effects of zinc and copper oxide nanoparticles and their miscibility simulations with polylactic acid. (10 Haziran 2025 tarihinde https://assets-eu.researchsquare.com/files/rs-4150189/v1_covered_09a78b87-c891-4d5a-ac8c-dae1a306347a.pdf adresinden ulaşılmıştır).
Siddiqi KS, Ur Rahman A, Tajuddin, et al. Biogenic fabrication of iron/iron oxide nanoparticles and their application. Nanoscale Research Letters. 2016;11(1): 498. https://doi.org/10.1186/s11671-016-1714-0.
Siddiqi KS, Husen A, Rao RAK. A review on biosynthesis of silver nanoparticles and their biocidal properties. Journal of nanobiotechnology. 2018;16(1): 14. doi:10.1186/s12951-018-0334-5.
Hajipour MJ, Fromm KM, Ashkarran AA, et al. Antibacterial properties of nanoparticles. Trends in Biotechnology. 2012;30(10): 499–511. doi:10.1016/j.tibtech.2012.06.004.
Jangid H, Joshi HC, Dutta J, et al. Advancing food safety with biogenic silver nanoparticles: Addressing antimicrobial resistance, sustainability, and commercial viability. Food Chemistry: X. 2025;102298. doi:10.1016/j.fochx.2025.102298.
Dumlu B. Importance of nano-sized feed additives in animal nutrition. Journal of Agricultural Production. 2024;5(1): 55–72. doi: 10.56430/japro.1433614.
Emamifar A, Kadivar M, Shahedi M, et al. Evaluation of nanocomposite packaging containing Ag and ZnO on shelf life of fresh orange juice. Innovative Food Science & Emerging Technologies. 2010;11(4): 742–748. doi:10.1016/j.ifset.2010.06.003.
Himanshu, Mukherjee R, Vidic J, et al. Nanobiotics and the One Health approach: Boosting the fight against antimicrobial resistance at the nanoscale. Biomolecules. 2023;13(8): 1182. doi:10.3390/biom13081182.
Anwar M, Muhammad F, Fatima S, et al. Innovative strategies for the control of zoonotic diseases by using nanotechnology. Unique Scientific Publishers. 2023;1: 198–210. doi:10.47278/book.zoon/2023.014.
Akbarzadeh A, Rezaei-Sadabady R, Davaran S, et al. Liposome: classification, preparation, and applications. Nanoscale Research Letters. 2013;8(1): 102. doi:10.1186/1556-276X-8-102.
Rizkita LD, Putri RGP, Farid M, et al. Liposome drug delivery in combating the widespread topical antibiotic resistance: a narrative review. Beni-Suef University Journal of Basic and Applied Sciences. 2024;13(1): 90. doi:10.1186/s43088-024-00545-2.
Huang Y, Guo X, Wu Y, et al. Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment. Signal Transduction and Targeted Therapy. 2024;9(1): 34. doi:10.1038/s41392-024-01745-z.
Kesharwani P, Jain K, Jain NK. Dendrimer as nanocarrier for drug delivery. Progress in Polymer Science. 2014;39(2): 268–307. doi:10.1016/j.progpolymsci.2013.07.005.
Kunjumon S, Krishnakumar K, Nair SK. Nanomicelles formulation: in vitro anti-fungal study. International Journal of Pharmaceutical Sciences Review and Research. 2020;62: 78–81.
Kalluru R, Fenaroli F, Westmoreland D, et al. Poly (lactide-co-glycolide)-rifampicin nanoparticles efficiently clear Mycobacterium bovis BCG infection in macrophages and remain membrane-bound in phago-lysosomes. Journal of Cell Science. 2013;126(14): 3043–3054. doi:10.1242/jcs.121814.
Voak AA, Harris A, Qaiser Z, et al. Pharmacodynamics and biodistribution of single-dose liposomal amphotericin B at different stages of experimental visceral leishmaniasis. Antimicrobial Agents and Chemotherapy. 2017;61(9): e00497–17. doi:10.1128/AAC.00497-17.
Das SS, Bharadwaj P, Bilal M, et al. Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis. Polymers. 2020;12(6): 1397. doi:10.3390/polym12061397.
Bartlett H, Holmes MA, Petrovan SO, et al. Understanding the relative risks of zoonosis emergence under contrasting approaches to meeting livestock product demand. Royal Society Open Science. 2022;9(6): 211573. doi:10.1098/rsos.211573.
Kuzma J. Nanotechnology in animal production—Upstream assessment of applications. Livestock Science. 2010;130(1-3): 14–24. doi:10.1016/j.livsci.2010.02.006.
Mohd Yusof H, Abdul Rahman N, Mohamad R, et al. Antibacterial potential of biosynthesized zinc oxide nanoparticles against poultry-associated foodborne pathogens: an in vitro study. Animals: An Open Access Journal from MDPI. 2021;11(7): 2093. doi:10.3390/ani11072093.
Husain S, Sultan RMS, Saxena K, et al. Nano selenium: A promising solution for infectious diseases-current status and future prospects. Current Pharmaceutical Design. 2025; 10.2174/0113816128346637250401090138. doi:10.2174/0113816128346637250401090138.
Sawosz E, Binek M, Grodzik M, et al. Influence of hydrocolloidal silver nanoparticles on gastrointestinal microflora and morphology of enterocytes of quails. Archives of Animal Nutrition. 2007;61(6): 444–451. doi:10.1080/17450390701664314.
Mohammed MA, Syeda JT, Wasan KM, Wasan EK. An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics. 2017;9(4): 53. doi:10.3390/pharmaceutics9040053.
Duffy LL, Osmond-McLeod MJ, Judy J, et al. Investigation into the antibacterial activity of silver, zinc oxide and copper oxide nanoparticles against poultry-relevant isolates of Salmonella and Campylobacter. Food Control. 2018;92: 293–300. doi:10.1016/j.foodcont.2018.05.008.
Kumaravel V, Nair KM, Mathew S, et al. Antimicrobial TiO2 nanocomposite coatings for surfaces, dental and orthopaedic implants. Chemical Engineering Journal (Lausanne, Switzerland: 1996). 2021;416: 129071. doi:10.1016/j.cej.2021.129071.
Griesche C, Baeumner AJ. Biosensors to support sustainable agriculture and food safety. TrAC Trends in Analytical Chemistry. 2020;128: 115906.
Pachepsky Y, Shelton DR, McLain JE, et al. Irrigation waters as a source of pathogenic microorganisms in produce: a review. Advances in Agronomy. 2011;113: 73–138.
Klaine SJ, Alvarez PJJ, Batley GE, et al. Nanomaterials in the environment: behavior, fate, bioavailability, and effects. Environmental Toxicology and Chemistry. 2008;27(9): 1825–1851. doi:10.1897/08-090.1.
Nel A, Xia T, Mädler L, et al. Toxic potential of materials at the nanolevel. Science (New York, N.Y.). 2006;311(5761): 622–627. doi:10.1126/science.1114397.
Singh K, Malla MA, Kumar A, et al. Comparative toxicity of zinc oxide nanoparticles and ionic zinc to earthworm Eudrilus eugeniae in soil matrix. Discover Soil. 2025;2(1): 17. doi:10.1007/s44378-025-00046-3.
Asharani PV, Wu YL, Gong Z, et al. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology. 2008;19(25): 255102. doi:10.1088/0957-4484/19/25/255102.
Nthunya LN, Mosai AK, López-Maldonado EA, et al. Unseen threats in aquatic and terrestrial ecosystems: Nanoparticle persistence, transport and toxicity in natural environments. Chemosphere. 2025;382: 144470. https://doi.org/10.1016/j.chemosphere.2025.144470.
Olaniyan OF, Ariwaodo CA, Ibrahim SO, et al. Advances in green synthesis and application of nanoparticles from crop residues: a comprehensive review. Scientific African. 2025;e02654. doi:10.1016/j.sciaf.2025.e02654.
Nizam NUM, Hanafiah MM, Woon KS. A content review of life cycle assessment of nanomaterials: current practices, challenges, and future prospects. Nanomaterials. 2021;11(12): 3324. doi:10.3390/nano11123324.
Huang R, Hu Q, Ko CN, et al. Nano-based theranostic approaches for infection control: current status and perspectives. Materials Chemistry Frontiers. 2024;8(1): 9–40. doi: 10.1039/D3QM01048A.
Khan H, Jan Z, Ullah I, et al. A deep dive into AI integration and advanced nanobiosensor technologies for enhanced bacterial infection monitoring. Nanotechnology Reviews. 2024;13(1): 20240056. doi:10.1515/ntrev-2024-0056.
Zhang X, Cui Z. Nanoparticle-based vaccines against zoonotic viruses: a review. Zoonoses. 2023;3(1):953. doi: 10.15212/ZOONOSES-2023-0018.
Schulte PA, Salamanca-Buentello F. Ethical and scientific issues of nanotechnology in the workplace. Environmental health perspectives 2007;115(1): 5–12. doi:10.1289/ehp.9456.
